Neurocrine Bioscience buy Cantor Fitzgerald
Start price
13.09.23
/
50%
€107.25
Target price
13.09.24
€126.70
Performance (%)
30.82%
Price
02.08.24
€140.30
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for Neurocrine Bioscience has seen massive gains of 30.82%. This prediction currently runs until 13.09.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 3.811% | 3.811% |
iShares Core DAX® | -3.935% | -3.998% |
iShares Nasdaq 100 | -3.608% | -9.386% |
iShares Nikkei 225® | -4.513% | -8.017% |
iShares S&P 500 | -2.607% | -4.265% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $136.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€136.10
25.07.24
25.07.24
€142.68
25.07.25
25.07.25
3.09%
02.08.24
02.08.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.55
10.04.24
10.04.24
€144.01
10.04.25
10.04.25
8.30%
02.08.24
02.08.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€102.55
24.10.23
24.10.23
-
24.10.24
24.10.24
35.69%
02.08.24
02.08.24